nocodazole has been researched along with quercetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meijer, L; Pondaven, P | 1 |
| Fadlalla, K; Samuel, T; Turner, T; Yehualaeshet, TE | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
4 other study(ies) available for nocodazole and quercetin
| Article | Year |
|---|---|
Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions.
Topics: Ammonium Chloride; Animals; Benzimidazoles; Cell Division; Colchicine; Emetine; Enzyme Activation; Female; Fertilization; Kinetics; Mitosis; Nocodazole; Oocytes; Protamine Kinase; Protein Biosynthesis; Protein Kinases; Quercetin; Sea Urchins | 1988 |
The flavonoid quercetin transiently inhibits the activity of taxol and nocodazole through interference with the cell cycle.
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin B1; Food-Drug Interactions; G2 Phase; Humans; Microtubules; Neoplasms; Nocodazole; Osmolar Concentration; Paclitaxel; Quercetin; Time Factors; Tubulin; Tubulin Modulators; Tumor Suppressor Protein p53 | 2010 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |